<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02331030</url>
  </required_header>
  <id_info>
    <org_study_id>2014/2047</org_study_id>
    <nct_id>NCT02331030</nct_id>
  </id_info>
  <brief_title>A Randomised Trial Comparing Supraclavicular Block vs Supraclavicular and Pecs II Block in Arteriovenous Grafting</brief_title>
  <official_title>A Randomised Controlled Trial Comparing Ultrasound-guided Supraclavicular Brachial Plexus Block With Combined Supraclavicular and Pecs II Block in Patients Undergoing Arteriovenous Grafting Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Changi General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Changi General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the addition of Pecs II block to ultrasound-guided supraclavicular
      brachial plexus block in patients undergoing arteriovenous graft creation surgery.
      Participants will be randomised into two equal groups, one receiving supraclavicular and pecs
      II blocks, the other receiving supraclavicular block and sham block (Grade 1).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Regional anaesthesia (RA) for arteriovenous grafting surgery has advantages of avoiding risks
      of general anaesthesia (GA) in this group of patients with significant co-morbidities, and
      beneficial vasodilatation, which may prevent early fistula thrombosis. Hence, RA is
      preferable to GA for this surgery.

      Brachial plexus blocks (BPB) are the most commonly employed RA technique to anaesthetise the
      upper limb for this surgery. According to the results of a recent 2-year retrospective audit
      in our centre, ultrasound-guided supraclavicular BPB are the most popular RA technique for
      this surgery. Anatomically, the T1 and T2 dermatomes are often missed by the supraclavicular
      BPB. This means that the upper medial arm and axilla (sites involved in brachiobasilic and
      brachioaxillary arteriovenous grafting) may not be adequately anaesthetised, mandating
      intraoperative local anaesthetic supplementation by the surgeon. This may affect patients'
      and surgeons' acceptance of, and satisfaction with the RA technique. The ultrasound-guided
      Pecs II block, described by Blanco et al, seems to address this problem, as the intercostal
      T1-6, intercostobrachialis, long thoracic nerves and nerve to serratus anterior are targeted
      by this block.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Need for intraoperative local anaesthetic supplementation by the surgeon</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Whether there was a need for the surgeon to infiltrate a standardised local anaesthetic drug (0.5% ropivacaine) to the operative site during surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Volume of intraoperative local anaesthetic supplementation administered</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Total volume of local anaesthetic drug (0.5% ropivacaine) given by the surgeon</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for additional sedation or systemic analgesia</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Whether there was a need for additional sedation or systemic analgesia (on top of what is specified in the protocol)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Highest pain score at Post-Anaesthesia Care Unit (PACU)</measure>
    <time_frame>Up to 1 hour post-operatively</time_frame>
    <description>Highest pain score on visual analogue scale at the post-anaesthesia care unit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first post-operative analgesia</measure>
    <time_frame>Up to 24 hours post-operatively</time_frame>
    <description>Duration of time from administration of the block(s) to when patient first requests for oral analgesia. Participants will be followed up for 24 hours after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score at 12h</measure>
    <time_frame>12 hours post-operatively</time_frame>
    <description>Pain score on visual analogue scale 12 hours after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain score at 24h</measure>
    <time_frame>24 hours post-operatively</time_frame>
    <description>Pain score on visual analogue scale 24 hours after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction at 24hours</measure>
    <time_frame>24 hours post-operatively</time_frame>
    <description>Patient satisfaction with the anaesthesia technique on a 5-point Likert scale 24 hours after surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">36</enrollment>
  <condition>Arteriovenous Fistula</condition>
  <condition>Arteriovenous Graft</condition>
  <condition>Kidney Failure, Chronic</condition>
  <condition>Renal Failure, End-stage</condition>
  <arm_group>
    <arm_group_label>Combined (C)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ultrasound-guided supraclavicular brachial plexus block with Ropivacaine 0.5% 20ml and Pecs II block with Ropivacaine 0.5% 10ml.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Supraclavicular (S)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound-guided supraclavicular BPB with Ropivacaine 0.5% 20ml and sham block (grade 1)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Supraclavicular</intervention_name>
    <description>Ultrasound-guided supraclavicular brachial plexus block</description>
    <arm_group_label>Combined (C)</arm_group_label>
    <arm_group_label>Supraclavicular (S)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pecs II block</intervention_name>
    <description>Ultrasound guided interfascial plane block between pectoralis minor and serratus anterior</description>
    <arm_group_label>Combined (C)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sham block (Grade 1)</intervention_name>
    <description>Sham block -- with skin preparation, ultrasound scanning of pecs II block area, but no actual needle injection</description>
    <arm_group_label>Supraclavicular (S)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 0.5% 20ml</intervention_name>
    <description>Local anaesthetic solution administered for supraclavicular block</description>
    <arm_group_label>Combined (C)</arm_group_label>
    <arm_group_label>Supraclavicular (S)</arm_group_label>
    <other_name>Naropin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine 0.5% 10ml</intervention_name>
    <description>Local anaesthetic solution administered for pecs II block</description>
    <arm_group_label>Combined (C)</arm_group_label>
    <other_name>Naropin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients scheduled for arteriovenous grafting under regional anaesthesia in Changi
             General Hospital

          -  American Society of Anaesthesiologists (ASA) physical status 3 to 4

          -  Elective or emergency surgery

        Exclusion Criteria:

          -  Patients unable to give consent, unable to communicate or cooperate with simple
             instructions

          -  Patients with regular consumption of strong opioids (eg. morphine, oxycodone) or
             steroids

          -  Patients with allergy or contraindications to local anaesthetics or any of the drugs
             included in this study

          -  Patients with pre-existing upper limb neurological deficits

          -  Patients who refuse or are unsuitable for regional anaesthesia (eg. severely
             coagulopathic)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kelvin Quek, MMED (Anaes)</last_name>
    <role>Principal Investigator</role>
    <affiliation>Changi General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Changi General Hospital</name>
      <address>
        <city>Singapore</city>
        <zip>529889</zip>
        <country>Singapore</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Singapore</country>
  </location_countries>
  <reference>
    <citation>Blanco R, Fajardo M, Parras Maldonado T. Ultrasound description of Pecs II (modified Pecs I): a novel approach to breast surgery. Rev Esp Anestesiol Reanim. 2012 Nov;59(9):470-5. doi: 10.1016/j.redar.2012.07.003. Epub 2012 Aug 29.</citation>
    <PMID>22939099</PMID>
  </reference>
  <reference>
    <citation>Arab SA, Alharbi MK, Nada EM, Alrefai DA, Mowafi HA. Ultrasound-guided supraclavicular brachial plexus block: single versus triple injection technique for upper limb arteriovenous access surgery. Anesth Analg. 2014 May;118(5):1120-5. doi: 10.1213/ANE.0000000000000155.</citation>
    <PMID>24686046</PMID>
  </reference>
  <reference>
    <citation>Reynolds TS, Kim KM, Dukkipati R, Nguyen TH, Julka I, Kakazu C, Tokhner V, Chauvapun JP. Pre-operative regional block anesthesia enhances operative strategy for arteriovenous fistula creation. J Vasc Access. 2011 Oct-Dec;12(4):336-40. doi: 10.5301/JVA.2011.8827.</citation>
    <PMID>22116664</PMID>
  </reference>
  <reference>
    <citation>Sahin L, Gul R, Mizrak A, Deniz H, Sahin M, Koruk S, Cesur M, Goksu S. Ultrasound-guided infraclavicular brachial plexus block enhances postoperative blood flow in arteriovenous fistulas. J Vasc Surg. 2011 Sep;54(3):749-53. doi: 10.1016/j.jvs.2010.12.045. Epub 2011 Mar 2.</citation>
    <PMID>21367563</PMID>
  </reference>
  <reference>
    <citation>Purcell N, Wu D. Novel use of the PECS II block for upper limb fistula surgery. Anaesthesia. 2014 Nov;69(11):1294. doi: 10.1111/anae.12876.</citation>
    <PMID>25302976</PMID>
  </reference>
  <reference>
    <citation>Sariguney D, Mahli A, Coskun D. The extent of blockade following axillary and infraclavicular approaches of brachial plexus block in uremic patients. J Clin Med Res. 2012 Feb;4(1):26-32. doi: 10.4021/jocmr723w. Epub 2012 Jan 17.</citation>
    <PMID>22383924</PMID>
  </reference>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 31, 2014</study_first_submitted>
  <study_first_submitted_qc>January 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 5, 2015</study_first_posted>
  <last_update_submitted>July 17, 2017</last_update_submitted>
  <last_update_submitted_qc>July 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Changi General Hospital</investigator_affiliation>
    <investigator_full_name>Kelvin Quek How Yow</investigator_full_name>
    <investigator_title>Consultant</investigator_title>
  </responsible_party>
  <keyword>brachio-axillary</keyword>
  <keyword>brachio-basilic</keyword>
  <keyword>interfascial plane block</keyword>
  <keyword>Pecs II block</keyword>
  <keyword>supraclavicular brachial plexus block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Arteriovenous Fistula</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Confidentiality of individual subjects will be maintained strictly</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

